Angina, Stable Clinical Trial
Official title:
Absolute Flow for Ischemia With No Obstructive Coronary Arteries
The main objective is to prospectively validate the capacity of continuous thermodilution coronary flow reserve (CFRflow) as a predictor of the presence of angina measured by SAQ7 in patients with INOCA at 3 months. Secondary objectives include identifying hemodynamic factors related to the persistence of angina at 3 and 12 months, identifying clinical factors associated with the persistence of angina, establishing the prevalence of patients with coronary microvascular dysfunction within the cohort of INOCA patients, identifying predictors of major cardiovascular events at 12 months, validating the pathological value of MMR and establishing the pathological value of AF measured in ml/min. The study also aims to evaluate the concordance between measures of the coronary microvascular function obtained by continuous thermodilution and bolus thermodilution, as well as their concordance with clinical characteristics.
Invasive study of microvascular function has become highly relevant for the diagnosis of alterations in coronary physiology for diagnostic, prognostic, and therapeutic purposes. Currently, the microvascular resistance index (IMR) is considered the gold standard for invasive diagnosis of coronary microvascular function, with a recommendation of 2A in the current clinical practice guidelines of the European Society of Cardiology. In recent years, technical innovation has allowed for the measurement of absolute coronary flow (AF) and minimal microvascular resistance (MMR) using continuous thermodilution, enabling the determination of quantitative flow and resistance units. However, the main limitation is the absence of reference values. Objectives: The main objective is to prospectively validate the capacity of CFRflow as a predictor of the presence of angina measured by SAQ7 in patients with INOCA at 3 months. Secondary objectives include identifying hemodynamic factors related to the persistence of angina at 3 and 12 months, identifying clinical factors related to the persistence of angina, establishing the prevalence of patients with coronary microvascular dysfunction within the cohort of INOCA patients, identifying predictors of major cardiovascular events at 12 months, validating the pathological value of MMR and establishing the pathological value of AF measured in ml/min. The study also aims to evaluate the concordance between measures of the coronary microvascular function obtained by continuous thermodilution and bolus thermodilution, as well as their concordance with clinical characteristics. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
| Recruiting |
NCT02870764 -
The Effect of Dan-shen Extract On Lipoprotein Associated PHospholipase A2 Levels IN Patients With Stable Angina Pectoris
|
Phase 4 | |
| Completed |
NCT04648306 -
Restore EF Observational Study
|
||
| Recruiting |
NCT05933083 -
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
|
N/A | |
| Not yet recruiting |
NCT02280850 -
Efficacy and Safety Study of Guanxin Shutong Capsule to Treat Chronic Stable Angina
|
Phase 4 | |
| Completed |
NCT04785846 -
Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
|
||
| Completed |
NCT03759067 -
Method of Clopidogrel Pre-treatment Undergoing Conventional Coronary Angiogram in Angina Patients
|
N/A | |
| Not yet recruiting |
NCT03306550 -
Mechanism of Drug-drug Interaction Between Salvianolate Injection and Aspirin
|
N/A | |
| Completed |
NCT03193294 -
CORonary MICrovascular Angina (CorMicA)
|
N/A | |
| Completed |
NCT04131816 -
HeartHome: A Nurse-Driven, Home-Based Cardiac Rehabilitation Program
|
N/A | |
| Recruiting |
NCT06075602 -
COMPLEX Registry - A Prospective COhort Study to Describe the Management and Outcomes of Patients Presenting With compLEX and Calcified Coronary Artery Disease
|
||
| Recruiting |
NCT03783351 -
Genotyping GUided Antiplatelet theRapy in pAtieNts Treated With Drug Eluting stEnts (GUARANTEE)
|
N/A | |
| Not yet recruiting |
NCT05857904 -
Clinical Outcomes of CT-FFR Versus QFR-guided Strategy for Decision-Making in Patients With Stable Chest Pain
|
N/A | |
| Recruiting |
NCT01838148 -
Biochemical and Electrocardiographic Signatures in the Detection of Exercise-induced Myocardial Ischemia
|
||
| Terminated |
NCT02914834 -
Acupuncture for Individuals With Stable Angina
|
N/A | |
| Not yet recruiting |
NCT06325020 -
Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology
|
||
| Completed |
NCT05804500 -
RecoveryPlus Telerehab Platform Pilot Study
|
N/A | |
| Completed |
NCT03518645 -
Optimal Lesion Preparation With Non-compliant Balloons Before Implantation Of Bioresorbable Scaffolds
|
N/A | |
| Terminated |
NCT01550614 -
Efficacy and Safety of Ad5FGF-4 for Myocardial Ischemia in Patients With Stable Angina Due to Coronary Artery Disease
|
Phase 3 | |
| Recruiting |
NCT05056662 -
Post-Revascularization Optimization and PHysiological Evaluation of intermediaTe Lesions
|